MedTrace Logo

Comprehensive Demographics and Clinical Profile of NSCLC Patients

NCT06725537 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-01-15

No results posted yet for this study

Summary

Advances in the treatment of non-small cell lung cancer in the last decade have been significant. Currently, there are several first-line therapeutic options. The molecular biology of the disease, biomarkers and the patient's clinical characteristics can assist in decision making. The study in question aims to retrospectively evaluate the patterns of choice in the first line treatment of metastatic non-small cell lung cancer without driver mutations, from 2019 to 2022 in 7 centers in Brazil.

Conditions

  • Lung Cancer Non Small Cell

Sponsors & Collaborators

Principal Investigators

  • Sofia V Mendes, MD · Instituto D'Or de Pesquisa e Ensino

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-20
Primary Completion
2025-03-01
Completion
2025-08-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06725537 on ClinicalTrials.gov